Shilpa Medicare to make Cadila's ZyCoV-D Covid vaccine
Indian health authorities had given emergency approval in August for Cadila's vaccine, the world's first Covid-19 DNA shot, in adults and children aged 12 years and above
India drug manufacturing firm Shilpa Medicare has entered into an agreement with Cadila Healthcare to manufacture its three-dose Covid-19 vaccine ZyCoV-D, the company said in a statement on Friday.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more